# Sarah Hanigan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sarah-hanigan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 170 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 6 |
| i10-index | 3 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5069755899 |
| ORCID iD | 0000-0003-4594-0496 |
| Works | 24 |

## Researcher papers

- [The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding](https://scholariq.org/papers/the-real-world-use-of-combined-p-glycoprotein-and-moderate-cyp3a4-inhibitors/)
- [Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl)](https://scholariq.org/papers/effects-of-total-dose-infusion-of-iron-intravenously-in-patients-with-acute/)
- [Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care](https://scholariq.org/papers/impact-of-a-guideline-for-the-management-of-antimicrobial-warfarin-interactions/)
- [Anti‐factor IIa (FIIa) heparin assay for patients on direct factor Xa (FXa) inhibitors](https://scholariq.org/papers/anti-factor-iia-fiia-heparin-assay-for-patients-on-direct-factor-xa-fxa/)
- [Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism](https://scholariq.org/papers/standard-versus-higher-intensity-anticoagulation-for-patients-with-mechanical/)
- [Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for <i><scp>C</scp>lostridium difficile</i>](https://scholariq.org/papers/effect-of-metronidazole-use-on-tacrolimus-concentrations-in-transplant-patients/)
- [Effect of Replacing Vendor QTc Alerts with a Custom QTc Risk Alert in Inpatients](https://scholariq.org/papers/effect-of-replacing-vendor-qtc-alerts-with-a-custom-qtc-risk-alert-in-inpatients/)
- [Evaluating pharmacokinetic drug–drug interactions of direct oral anticoagulants in patients with renal dysfunction](https://scholariq.org/papers/evaluating-pharmacokinetic-drug-drug-interactions-of-direct-oral-anticoagulants/)
- [Higher Intensity Statin Therapy Reduces Clinical Endpoints after Heart Transplantation Independent of Lipid Levels](https://scholariq.org/papers/higher-intensity-statin-therapy-reduces-clinical-endpoints-after-heart/)
- [Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure](https://scholariq.org/papers/real-world-prevalence-of-adverse-events-after-initiating-sacubitril-valsartan/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.